Skip to main content
Top
Gepubliceerd in: Quality of Life Research 10/2016

01-10-2016

Refined comorbidity index based on dimensionality of comorbidity for use in studies of health-related quality of life

Auteurs: Huang-Tz Ou, Chung-Ying Lin, Steven R. Erickson, Rajesh Balkrishnan

Gepubliceerd in: Quality of Life Research | Uitgave 10/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To refine two subscales of the health-related quality of life comorbidity index (HRQoL-CI) into a single index measure.

Methods

The 2010 and 2012 Medical Expenditure Panel Surveys were utilized as development and validation datasets, respectively. The least absolute shrinkage and selection operator was applied to select important comorbidity candidates associated with HRQoL. Exploratory factor analysis and confirmatory factor analysis (CFA) were used to assess dimensionality in comorbidity. Statistical weights were derived based on standardized factor loadings from CFA and regression coefficients from the model predicting HRQoL. Prediction errors and model R2 values were compared between HRQoL-CI and Charlson CI (CCI).

Results

Eighteen comorbid conditions were identified. CFA models indicated that the second-order multidimensional comorbidity structure had a better fit to the data than did the first-order unidimensional structure. The predictive performance of the refined scale under a multidimensional structure utilizing statistical weights outperformed the original scale and CCI in terms of average prediction error and R2 in the prediction models (R2 values from refined scale model are 0.25, 0.30, and 0.28 versus those from CCI of 0.10, 0.09, and 0.06 for general health, SF-6D, and EQ-5D, respectively).

Conclusion

The dimensionality of comorbidity and the weight scheme significantly improved the performance of the refined HRQoL-CI. The refined single HRQoL-CI measure appears to be an appropriate and valid instrument specific for risk adjustment in studies of HRQoL. Future research that validates the refined scales for different cultures, age groups, and healthcare settings is warranted.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Wu, S. Y., & Green, A. (2000). Projection of chronic illness prevalence and cost inflation. Washington, DC: RAND Health. Wu, S. Y., & Green, A. (2000). Projection of chronic illness prevalence and cost inflation. Washington, DC: RAND Health.
2.
go back to reference van den Akker, M., Buntinx, F., Metsemakers, J. F., Roos, S., & Knottnerus, J. A. (1998). Multimorbidity in general practice: Prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. Journal of Clinical Epidemiology, 51(5), 367–375.CrossRefPubMed van den Akker, M., Buntinx, F., Metsemakers, J. F., Roos, S., & Knottnerus, J. A. (1998). Multimorbidity in general practice: Prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. Journal of Clinical Epidemiology, 51(5), 367–375.CrossRefPubMed
3.
go back to reference Knottnerus, J. A., Metsemakers, J., Hoppener, P., & Limonard, C. (1992). Chronic illness in the community and the concept of ‘social prevalence’. Family Practice, 9(1), 15–21.CrossRefPubMed Knottnerus, J. A., Metsemakers, J., Hoppener, P., & Limonard, C. (1992). Chronic illness in the community and the concept of ‘social prevalence’. Family Practice, 9(1), 15–21.CrossRefPubMed
4.
go back to reference Schellevis, F. G., van der Velden, J., van de Lisdonk, E., van Eijk, J. T., & van Weel, C. (1993). Comorbidity of chronic diseases in general practice. Journal of Clinical Epidemiology, 46(5), 469–473.CrossRefPubMed Schellevis, F. G., van der Velden, J., van de Lisdonk, E., van Eijk, J. T., & van Weel, C. (1993). Comorbidity of chronic diseases in general practice. Journal of Clinical Epidemiology, 46(5), 469–473.CrossRefPubMed
5.
go back to reference Metsemakers, J. F., Hoppener, P., Knottnerus, J. A., Kocken, R. J., & Limonard, C. B. (1992). Computerized health information in The Netherlands: A registration network of family practices. British Journal of General Practice, 42(356), 102–106.PubMedPubMedCentral Metsemakers, J. F., Hoppener, P., Knottnerus, J. A., Kocken, R. J., & Limonard, C. B. (1992). Computerized health information in The Netherlands: A registration network of family practices. British Journal of General Practice, 42(356), 102–106.PubMedPubMedCentral
6.
go back to reference Wolff, J. L., Starfield, B., & Anderson, G. (2002). Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Archives of Internal Medicine, 162(20), 2269–2276.CrossRefPubMed Wolff, J. L., Starfield, B., & Anderson, G. (2002). Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Archives of Internal Medicine, 162(20), 2269–2276.CrossRefPubMed
7.
go back to reference Jones, C. A., Voaklander, D. C., Johnston, D. W., & Suarez-Almazor, M. E. (2000). Health related quality of life outcomes after total hip and knee arthroplasties in a community based population. The Journal of rheumatology, 27(7), 1745–1752.PubMed Jones, C. A., Voaklander, D. C., Johnston, D. W., & Suarez-Almazor, M. E. (2000). Health related quality of life outcomes after total hip and knee arthroplasties in a community based population. The Journal of rheumatology, 27(7), 1745–1752.PubMed
8.
go back to reference Jones, C. A., Voaklander, D. C., Johnston, D. W., & Suarez-Almazor, M. E. (2001). The effect of age on pain, function, and quality of life after total hip and knee arthroplasty. Archives of Internal Medicine, 161(3), 454–460.CrossRefPubMed Jones, C. A., Voaklander, D. C., Johnston, D. W., & Suarez-Almazor, M. E. (2001). The effect of age on pain, function, and quality of life after total hip and knee arthroplasty. Archives of Internal Medicine, 161(3), 454–460.CrossRefPubMed
9.
go back to reference Smith, A. W., Reeve, B. B., Bellizzi, K. M., Harlan, L. C., Klabunde, C. N., Amsellem, M., et al. (2008). Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev, 29(4), 41–56.PubMedPubMedCentral Smith, A. W., Reeve, B. B., Bellizzi, K. M., Harlan, L. C., Klabunde, C. N., Amsellem, M., et al. (2008). Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev, 29(4), 41–56.PubMedPubMedCentral
10.
go back to reference Hays, R. D., Cunningham, W. E., Sherbourne, C. D., Wilson, I. B., Wu, A. W., Cleary, P. D., et al. (2000). Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV Cost and Services Utilization Study. American Journal of Medicine, 108(9), 714–722.CrossRefPubMed Hays, R. D., Cunningham, W. E., Sherbourne, C. D., Wilson, I. B., Wu, A. W., Cleary, P. D., et al. (2000). Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV Cost and Services Utilization Study. American Journal of Medicine, 108(9), 714–722.CrossRefPubMed
11.
go back to reference Richardson, L. C., Wingo, P. A., Zack, M. M., Zahran, H. S., & King, J. B. (2008). Health-related quality of life in cancer survivors between ages 20 and 64 years: Population-based estimates from the Behavioral Risk Factor Surveillance System. Cancer, 112(6), 1380–1389.CrossRefPubMed Richardson, L. C., Wingo, P. A., Zack, M. M., Zahran, H. S., & King, J. B. (2008). Health-related quality of life in cancer survivors between ages 20 and 64 years: Population-based estimates from the Behavioral Risk Factor Surveillance System. Cancer, 112(6), 1380–1389.CrossRefPubMed
12.
go back to reference Vogeli, C., Shields, A. E., Lee, T. A., Gibson, T. B., Marder, W. D., Weiss, K. B., et al. (2007). Multiple chronic conditions: Prevalence, health consequences, and implications for quality, care management, and costs. Journal of General Internal Medicine, 22(Suppl 3), 391–395.CrossRefPubMedPubMedCentral Vogeli, C., Shields, A. E., Lee, T. A., Gibson, T. B., Marder, W. D., Weiss, K. B., et al. (2007). Multiple chronic conditions: Prevalence, health consequences, and implications for quality, care management, and costs. Journal of General Internal Medicine, 22(Suppl 3), 391–395.CrossRefPubMedPubMedCentral
13.
go back to reference Lash, T. L., Mor, V., Wieland, D., Ferrucci, L., Satariano, W., & Silliman, R. A. (2007). Methodology, design, and analytic techniques to address measurement of comorbid disease. The journals of gerontology. Series A, Biological sciences and medical sciences, 62(3), 281–285.CrossRefPubMedPubMedCentral Lash, T. L., Mor, V., Wieland, D., Ferrucci, L., Satariano, W., & Silliman, R. A. (2007). Methodology, design, and analytic techniques to address measurement of comorbid disease. The journals of gerontology. Series A, Biological sciences and medical sciences, 62(3), 281–285.CrossRefPubMedPubMedCentral
14.
go back to reference Iezzoni, L. I. (1997). Dimensions of risk. In L. I. Iezzoni (Ed.), Risk adjustment for measuring healthcare outcomes. Chicago, IL: Health Administration Press. Iezzoni, L. I. (1997). Dimensions of risk. In L. I. Iezzoni (Ed.), Risk adjustment for measuring healthcare outcomes. Chicago, IL: Health Administration Press.
15.
go back to reference Kaplan, M. H., & Feinstein, A. R. (1974). The importance of classifying initial co-morbidity in evaluation the outcome of diabetes mellitus. Journal of chronic diseases, 27(7–8), 387–404.CrossRefPubMed Kaplan, M. H., & Feinstein, A. R. (1974). The importance of classifying initial co-morbidity in evaluation the outcome of diabetes mellitus. Journal of chronic diseases, 27(7–8), 387–404.CrossRefPubMed
16.
go back to reference Fishman, P. A., Goodman, M. J., Hornbrook, M. C., Meenan, R. T., Bachman, D. J., & O’Keeffe Rosetti, M. C. (2003). Risk adjustment using automated ambulatory pharmacy data: The RxRisk model. Medical Care, 41(1), 84–99.CrossRefPubMed Fishman, P. A., Goodman, M. J., Hornbrook, M. C., Meenan, R. T., Bachman, D. J., & O’Keeffe Rosetti, M. C. (2003). Risk adjustment using automated ambulatory pharmacy data: The RxRisk model. Medical Care, 41(1), 84–99.CrossRefPubMed
17.
go back to reference Clark, D. O., Von Korff, M., Saunders, K., Baluch, W. M., & Simon, G. E. (1995). A chronic disease score with empirically derived weights. Medical Care, 33(8), 783–795.CrossRefPubMed Clark, D. O., Von Korff, M., Saunders, K., Baluch, W. M., & Simon, G. E. (1995). A chronic disease score with empirically derived weights. Medical Care, 33(8), 783–795.CrossRefPubMed
18.
go back to reference Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998). Comorbidity measures for use with administrative data. Medical Care, 36(1), 8–27.CrossRefPubMed Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998). Comorbidity measures for use with administrative data. Medical Care, 36(1), 8–27.CrossRefPubMed
19.
go back to reference Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of chronic diseases, 40(5), 373–383.CrossRefPubMed Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of chronic diseases, 40(5), 373–383.CrossRefPubMed
20.
go back to reference Linn, B. S., Linn, M. W., & Gurel, L. (1968). Cumulative illness rating scale. Journal of the American Geriatrics Society, 16(5), 622–626.CrossRefPubMed Linn, B. S., Linn, M. W., & Gurel, L. (1968). Cumulative illness rating scale. Journal of the American Geriatrics Society, 16(5), 622–626.CrossRefPubMed
21.
go back to reference Mukherjee, B., Ou, H.-T., Wang, F., & Erickson, S. R. (2011). A new comorbidity index: The health-related quality of life comorbidity index. Journal of Clinical Epidemiology, 64(3), 309–319.CrossRefPubMed Mukherjee, B., Ou, H.-T., Wang, F., & Erickson, S. R. (2011). A new comorbidity index: The health-related quality of life comorbidity index. Journal of Clinical Epidemiology, 64(3), 309–319.CrossRefPubMed
22.
go back to reference Groll, D. L., To, T., Bombardier, C., & Wright, J. G. (2005). The development of a comorbidity index with physical function as the outcome. Journal of Clinical Epidemiology, 58(6), 595–602.CrossRefPubMed Groll, D. L., To, T., Bombardier, C., & Wright, J. G. (2005). The development of a comorbidity index with physical function as the outcome. Journal of Clinical Epidemiology, 58(6), 595–602.CrossRefPubMed
23.
go back to reference Extermann, M., Overcash, J., Lyman, G. H., Parr, J., & Balducci, L. (1998). Comorbidity and functional status are independent in older cancer patients. Journal of Clinical Oncology, 16(4), 1582–1587.PubMed Extermann, M., Overcash, J., Lyman, G. H., Parr, J., & Balducci, L. (1998). Comorbidity and functional status are independent in older cancer patients. Journal of Clinical Oncology, 16(4), 1582–1587.PubMed
24.
go back to reference Repetto, L., Fratino, L., Audisio, R. A., Venturino, A., Gianni, W., Vercelli, M., et al. (2002). Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: An Italian Group for Geriatric Oncology Study. Journal of Clinical Oncology, 20(2), 494–502.CrossRefPubMed Repetto, L., Fratino, L., Audisio, R. A., Venturino, A., Gianni, W., Vercelli, M., et al. (2002). Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: An Italian Group for Geriatric Oncology Study. Journal of Clinical Oncology, 20(2), 494–502.CrossRefPubMed
25.
go back to reference Rothrock, N. E., Hays, R. D., Spritzer, K., Yount, S. E., Riley, W., & Cella, D. (2010). Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). Journal of Clinical Epidemiology, 63(11), 1195–1204.CrossRefPubMedPubMedCentral Rothrock, N. E., Hays, R. D., Spritzer, K., Yount, S. E., Riley, W., & Cella, D. (2010). Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). Journal of Clinical Epidemiology, 63(11), 1195–1204.CrossRefPubMedPubMedCentral
26.
go back to reference Ou, H.-T., Mukherjee, B., Erickson, S. R., Piette, J. D., Bagozzi, R. P., & Balkrishnan, R. (2011). Comparative performance of comorbidity indices in discriminating health-related behaviors and outcomes. Health Outcomes Research in Medicine, 2(2), e91–e104.CrossRef Ou, H.-T., Mukherjee, B., Erickson, S. R., Piette, J. D., Bagozzi, R. P., & Balkrishnan, R. (2011). Comparative performance of comorbidity indices in discriminating health-related behaviors and outcomes. Health Outcomes Research in Medicine, 2(2), e91–e104.CrossRef
27.
go back to reference Ou, H.-T., Mukherjee, B., Erickson, S. R., Piette, J. D., Bagozzi, R. P., & Balkrishnan, R. (2012). Comparative performance of comorbidity indices in predicting health care-related behaviors and outcomes among medicaid enrollees with type 2 diabetes. Population Health Management, 15(4), 220–229.CrossRefPubMedPubMedCentral Ou, H.-T., Mukherjee, B., Erickson, S. R., Piette, J. D., Bagozzi, R. P., & Balkrishnan, R. (2012). Comparative performance of comorbidity indices in predicting health care-related behaviors and outcomes among medicaid enrollees with type 2 diabetes. Population Health Management, 15(4), 220–229.CrossRefPubMedPubMedCentral
28.
go back to reference Deyo, R. A., Cherkin, D. C., & Ciol, M. A. (1992). Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology, 45(6), 613–619.CrossRefPubMed Deyo, R. A., Cherkin, D. C., & Ciol, M. A. (1992). Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology, 45(6), 613–619.CrossRefPubMed
29.
go back to reference Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994). Validation of a combined comorbidity index. Journal of Clinical Epidemiology, 47(11), 1245–1251.CrossRefPubMed Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994). Validation of a combined comorbidity index. Journal of Clinical Epidemiology, 47(11), 1245–1251.CrossRefPubMed
30.
go back to reference D’Hoore, W., Bouckaert, A., & Tilquin, C. (1996). Practical considerations on the use of the Charlson comorbidity index with administrative data bases. Journal of Clinical Epidemiology, 49(12), 1429–1433.CrossRefPubMed D’Hoore, W., Bouckaert, A., & Tilquin, C. (1996). Practical considerations on the use of the Charlson comorbidity index with administrative data bases. Journal of Clinical Epidemiology, 49(12), 1429–1433.CrossRefPubMed
31.
go back to reference D’Hoore, W., Sicotte, C., & Tilquin, C. (1993). Risk adjustment in outcome assessment: The Charlson comorbidity index. Methods of Information in Medicine, 32(5), 382–387.PubMed D’Hoore, W., Sicotte, C., & Tilquin, C. (1993). Risk adjustment in outcome assessment: The Charlson comorbidity index. Methods of Information in Medicine, 32(5), 382–387.PubMed
32.
go back to reference Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.CrossRefPubMed Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.CrossRefPubMed
33.
go back to reference EuroQol, G. (1990). EuroQol–a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef EuroQol, G. (1990). EuroQol–a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
34.
go back to reference Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43(3), 203–220.CrossRefPubMed Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43(3), 203–220.CrossRefPubMed
35.
go back to reference Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society. Series B (Methodological), 58(1), 267–288. Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society. Series B (Methodological), 58(1), 267–288.
36.
go back to reference Christoffersson, A. (1975). Factor analysis of dichotomized variables. Psychometrika, 40(1), 5–32.CrossRef Christoffersson, A. (1975). Factor analysis of dichotomized variables. Psychometrika, 40(1), 5–32.CrossRef
37.
go back to reference Schumacker, R. E., & Lomax, R. G. (2004). A beginner’s guide to structural equation modeling (2nd ed.). Mahwah, NJ: Lawrence Erlbaum Associates. Schumacker, R. E., & Lomax, R. G. (2004). A beginner’s guide to structural equation modeling (2nd ed.). Mahwah, NJ: Lawrence Erlbaum Associates.
38.
go back to reference Marsh, H. W., Hau, K. T., & Wen, Z. (2004). In search of golden rules: Comment on hypothesis-testing approaches to setting cutoff values for fit indices and dangers in overgeneralizing Hu and Bentler’s (1999). Structural Equation Modeling, 11, 320–341.CrossRef Marsh, H. W., Hau, K. T., & Wen, Z. (2004). In search of golden rules: Comment on hypothesis-testing approaches to setting cutoff values for fit indices and dangers in overgeneralizing Hu and Bentler’s (1999). Structural Equation Modeling, 11, 320–341.CrossRef
39.
go back to reference Hu, L., & Bentler, P. M. (1998). Fit indices in covariance structure analysis: Sensitivity to under-parameterized model misspecification. Psychological Methods, 3, 424–453.CrossRef Hu, L., & Bentler, P. M. (1998). Fit indices in covariance structure analysis: Sensitivity to under-parameterized model misspecification. Psychological Methods, 3, 424–453.CrossRef
40.
go back to reference Baumgartner, H., & Homburg, C. (1996). Applications of structural equation modeling in marketing and consumer research: A review. International Journal of Research in Marketing, 13(2), 139–161.CrossRef Baumgartner, H., & Homburg, C. (1996). Applications of structural equation modeling in marketing and consumer research: A review. International Journal of Research in Marketing, 13(2), 139–161.CrossRef
41.
go back to reference Breusch, T. S., & Pagan, A. R. (1979). A simple test for heteroscedasticity and random coefficient variation. Econometrica: Journal of the Econometric Society, 47(5), 1287–1294.CrossRef Breusch, T. S., & Pagan, A. R. (1979). A simple test for heteroscedasticity and random coefficient variation. Econometrica: Journal of the Econometric Society, 47(5), 1287–1294.CrossRef
42.
go back to reference Petrou, S., & Hockley, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189.CrossRefPubMed Petrou, S., & Hockley, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189.CrossRefPubMed
Metagegevens
Titel
Refined comorbidity index based on dimensionality of comorbidity for use in studies of health-related quality of life
Auteurs
Huang-Tz Ou
Chung-Ying Lin
Steven R. Erickson
Rajesh Balkrishnan
Publicatiedatum
01-10-2016
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 10/2016
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-016-1306-6

Andere artikelen Uitgave 10/2016

Quality of Life Research 10/2016 Naar de uitgave